• MJHLS Brand Logo

© 2026 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.

Discussing Rapid Accurate mRNA Potency Assay Possibilities with Sean Hart

Published on: 

Sean Hart, CEO and SCO of LumaCyte, discusses rapid accurate mRNA potency assay possibilities.

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on the topic of rapid accurate mRNA potency assay possibilities.

Related Content:

Drug DevelopmentBusinessBusiness Videos
Personalized Medicine vs. Precision Medicine
The Benefits of an Immune-Directed ADC Strategy
Gene Therapy, Rare Diseases, and Transfer RNA